Literature DB >> 26741994

The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.

Melpomeni Tseliou1, Ahmed Al-Qahtani, Saud Alarifi, Saad H Alkahtani, Christos Stournaras, George Sourvinos.   

Abstract

BACKGROUND/AIMS: Rho GTPases are crucial regulators of the actin cytoskeleton, membrane trafficking and cell signaling and their importance in cell migration and invasion is well- established. The human cytomegalovirus (HCMV) is a widespread pathogen responsible for generally asymptomatic and persistent infections in healthy people. Recent evidence indicates that HCMV gene products are expressed in over 90% of malignant type glioblastomas (GBM). In addition, the HCMV Immediate Early-1 protein (IE1) is expressed in >90% of tumors analyzed.
METHODS: RhoA, RhoB and RhoC were individually depleted in U373MG glioblastoma cells as well as U373MG cells stably expressing the HCMV IE1 protein (named U373MG-IE1 cells) shRNA lentivirus vectors. Cell proliferation assays, migration as well as wound-healing assays were performed in uninfected and HCMV-infected cells.
RESULTS: The depletion of RhoA, RhoB and RhoC protein resulted in significant alterations in the morphology of the uninfected cells, which were further enhanced by the cytopathic effect caused by HCMV. Furthermore, in the absence or presence of HCMV, the knockdown of RhoB and RhoC proteins decreased the proliferation rate of the parental and the IE1-expressing glioblastoma cells, whereas the knockdown of RhoA protein in the HCMV infected cell lines restored their proliferation rate. In addition, wound healing assays in U373MG cells revealed that depletion of RhoA, RhoB and RhoC differentially reduced their migration rate, even in the presence or the absence of HCMV.
CONCLUSION: Collectively, these data show for the first time a differential implication of Rho GTPases in morphology, proliferation rate and motility of human glioblastoma cells during HCMV infection, further supporting an oncomodulatory role of HCMV depending on the Rho isoforms' state.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26741994     DOI: 10.1159/000438612

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  19 in total

1.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.

Authors:  Andrew S Venteicher; Itay Tirosh; Christine Hebert; Keren Yizhak; Cyril Neftel; Mariella G Filbin; Volker Hovestadt; Leah E Escalante; McKenzie L Shaw; Christopher Rodman; Shawn M Gillespie; Danielle Dionne; Christina C Luo; Hiranmayi Ravichandran; Ravindra Mylvaganam; Christopher Mount; Maristela L Onozato; Brian V Nahed; Hiroaki Wakimoto; William T Curry; A John Iafrate; Miguel N Rivera; Matthew P Frosch; Todd R Golub; Priscilla K Brastianos; Gad Getz; Anoop P Patel; Michelle Monje; Daniel P Cahill; Orit Rozenblatt-Rosen; David N Louis; Bradley E Bernstein; Aviv Regev; Mario L Suvà
Journal:  Science       Date:  2017-03-31       Impact factor: 47.728

2.  ROCK1-PredictedmicroRNAs Dysregulation Contributes to Tumor Progression in Ewing Sarcoma.

Authors:  G M Roberto; L E A Delsin; G M Vieira; M O Silva; R G Hakime; N F Gava; E E Engel; C A Scrideli; L G Tone; María Sol Brassesco
Journal:  Pathol Oncol Res       Date:  2017-12-21       Impact factor: 3.201

3.  MicroRNA-137 inhibits growth of glioblastoma through EGFR suppression.

Authors:  Zhenxing Zhang; Xiaofeng Song; He Tian; Ye Miao; Xu Feng; Yang Li; Honglei Wang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

4.  The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.

Authors:  Nefeli Zacharopoulou; Galatea Kallergi; Saad Alkahtani; Anna Tsapara; Saud Alarifi; Evi Schmid; Basma Sukkar; Sotirios Kampranis; Florian Lang; Christos Stournaras
Journal:  Cancer Biol Ther       Date:  2020-03-16       Impact factor: 4.742

5.  Gene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.

Authors:  Anna Huhtinen; Vesa Hongisto; Asta Laiho; Eliisa Löyttyniemi; Dirk Pijnenburg; Mika Scheinin
Journal:  BMC Syst Biol       Date:  2017-06-28

6.  Expression of Rho GTPases family in melanoma cells and its influence on cytoskeleton and migration.

Authors:  Si-Jian Wen; Wei Zhang; Na-Na Ni; Qiong Wu; Xiao-Po Wang; You-Kun Lin; Jian-Fang Sun
Journal:  Oncotarget       Date:  2017-05-02

7.  RhoA promotes epidermal stem cell proliferation via PKN1-cyclin D1 signaling.

Authors:  Fan Wang; Rixing Zhan; Liang Chen; Xia Dai; Wenping Wang; Rui Guo; Xiaoge Li; Zhe Li; Liang Wang; Shupeng Huang; Jie Shen; Shirong Li; Chuan Cao
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

8.  Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation.

Authors:  Luciana Bueno De Paiva; Vanessa Aline Bernusso; João Agostinho Machado-Neto; Fabiola Traina; Anne J Ridley; Sara Teresinha Olalla-Saad; Mariana Lazarini
Journal:  Small GTPases       Date:  2018-11-18

Review 9.  Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

Review 10.  Cyclophilin A as a target in the treatment of cytomegalovirus infections.

Authors:  Ashwaq A Abdullah; Rasedee Abdullah; Zeenathul A Nazariah; Krishnan N Balakrishnan; Faez Firdaus J Abdullah; Jamilu A Bala; Mohd-Azmi Mohd-Lila
Journal:  Antivir Chem Chemother       Date:  2018 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.